Avesthagen Completes The First Whole Genome Sequence Of A Parsi Breast Cancer Patient

[News]

Avesthagen Limited has yet again established its position as a leader in the successful application of next gen technologies as it announces the completion of the first Parsi breast cancer whole genome sequence of a 74-year-old Parsi woman with a heritable form of breast cancer...

More... (http://mnt.to/f/3PDq)